The CD39+ HBV surface protein-targeted CAR-T and personalized tumor-reactive CD8+ T cells exhibit potent anti-HCC activity

Fan Zou; Jizhou Tan; Ting Liu; Bingfeng Liu; Ya‐Ping Tang; Hui Zhang; Jiaping Li

doi:10.1016/j.ymthe.2021.01.021

The CD39+ HBV surface protein-targeted CAR-T and personalized tumor-reactive CD8+ T cells exhibit potent anti-HCC activity

Fan Zou(Ministry of Education of the People's Republic of China), Jizhou Tan(Sun Yat-sen University), Ting Liu(Sun Yat-sen University), Bingfeng Liu(Ministry of Education of the People's Republic of China), Ya‐Ping Tang(Sun Yat-sen University), Hui Zhang(Ministry of Education of the People's Republic of China), Jiaping Li(Sun Yat-sen University)

Molecular Therapy

January 21, 2021

10.1016/j.ymthe.2021.01.021

Cited by 121Open Access

Full Text

Abstract

Related Papers

No related papers found

Powered by citation graph analysis